Kevin Hadi

Kevin Hadi is a Computational Biologist at Isabl since April 2022, with a robust background in biostatistics and cancer genomics from a PhD conducted at Weill Cornell Medicine. During the tenure as a PhD candidate from May 2016 to April 2022, Kevin demonstrated strong analytic skills through R programming and statistical learning, contributing to four landmark publications, including a first-author article in *Cell*. Kevin’s collaborative efforts extended beyond Weill Cornell, engaging in research with prestigious institutions such as the Fred Hutchinson Cancer Research Center and Memorial Sloan Kettering Cancer Center. Kevin's academic accomplishments include receiving a three-year NIH F31 Research Fellowship and serving as a teaching assistant, while prior experience as a Research Specialist and Graduate Student Researcher at the University of Pittsburgh involved optimizing clinical research methodologies and characterizing pathogenic mechanisms in HIV. Kevin holds a PhD in Biomathematics, Bioinformatics, and Computational Biology, as well as degrees in Infectious Diseases and Microbiology, and Neuroscience from the University of Pittsburgh.